The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.
Northwestern Medicine clinicians are at the forefront in using an advanced surgical treatment called deep brain stimulation to improve quality of life for patients with Parkinson’s and other movement disorders.
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
Scientists have developed the first example of a bioresorbable electronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.